VEROVACCiNES closes Series B financing
On the 14th of October 2021 the vaccine specialist VEROVACCiNES GmbH completed their Mid-Seven-Figure Series B financing round with investors from Germany and Switzerland. According to the company these funds […]
On the 14th of October 2021 the vaccine specialist VEROVACCiNES GmbH completed their Mid-Seven-Figure Series B financing round with investors from Germany and Switzerland. According to the company these funds will be used to further validate the innovative platform technology as well as the portfolio of animal vaccines.
More information can be found here.
You may also be interested in
8 weeks after the start of the Weinberg Campus Accelerator
Who is part of it? What happened so far and what is the outlook? About 8 weeks of the Startup-Accelerator have passed which means we are almost halfway through the […]
Read More 
IdentMe wins Biodiversity Challenge
The Weinberg Campus Accelerator Startup Team IdentMe convinced the jury of the Biodiversity Challenge with their pitch deck and their innovative idea to detect rare and protected species with eDNA-analysis. […]
Read More 
Starting a Business: 10 Things You Need to Do
Starting a Business is not an easy undertaking…especially when you have zero experience. Therefore, we made a list of things you need to do to found your own company. So […]
Read More